178 related articles for article (PubMed ID: 12456626)
1. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial.
Palomba S; Russo T; Orio F; Tauchmanovà L; Zupi E; Panici PL; Nappi C; Colao A; Lombardi G; Zullo F
Hum Reprod; 2002 Dec; 17(12):3213-9. PubMed ID: 12456626
[TBL] [Abstract][Full Text] [Related]
2. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
3. Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism.
Palomba S; Orio F; Morelli M; Russo T; Pellicano M; Nappi C; Mastrantonio P; Lombardi G; Colao A; Zullo F
J Clin Endocrinol Metab; 2002 Oct; 87(10):4476-81. PubMed ID: 12364422
[TBL] [Abstract][Full Text] [Related]
4. Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.
Palomba S; Russo T; Orio F; Sammartino A; Sbano FM; Nappi C; Colao A; Mastrantonio P; Lombardi G; Zullo F
Hum Reprod; 2004 Feb; 19(2):415-21. PubMed ID: 14747190
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.
Jirecek S; Lee A; Pavo I; Crans G; Eppel W; Wenzl R
Fertil Steril; 2004 Jan; 81(1):132-6. PubMed ID: 14711556
[TBL] [Abstract][Full Text] [Related]
6. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.
Palomba S; Sammartino A; Di Carlo C; Affinito P; Zullo F; Nappi C
Fertil Steril; 2001 Jul; 76(1):38-43. PubMed ID: 11438317
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Wu T; Chen X; Xie L
Cochrane Database Syst Rev; 2007 Oct; (4):CD005287. PubMed ID: 17943846
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Lingxia X; Taixiang W; Xiaoyan C
Cochrane Database Syst Rev; 2007 Apr; (2):CD005287. PubMed ID: 17443581
[TBL] [Abstract][Full Text] [Related]
9. Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas.
Palomba S; Orio F; Falbo A; Oppedisano R; Tolino A; Zullo F
Fertil Steril; 2008 Jul; 90(1):165-73. PubMed ID: 18001721
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study.
Palomba S; Orio F; Morelli M; Russo T; Pellicano M; Zupi E; Lombardi G; Nappi C; Panici PL; Zullo F
J Clin Endocrinol Metab; 2002 Aug; 87(8):3603-8. PubMed ID: 12161482
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Deng L; Wu T; Chen XY; Xie L; Yang J
Cochrane Database Syst Rev; 2012 Oct; 10():CD005287. PubMed ID: 23076912
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
Palomba S; Pellicano M; Affinito P; Di Carlo C; Zullo F; Nappi C
Fertil Steril; 2001 Feb; 75(2):429-33. PubMed ID: 11172852
[TBL] [Abstract][Full Text] [Related]
13. GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group.
Stovall TG; Muneyyirci-Delale O; Summitt RL; Scialli AR
Obstet Gynecol; 1995 Jul; 86(1):65-71. PubMed ID: 7784025
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women.
Palomba S; Orio F; Russo T; Falbo A; Tolino A; Lombardi G; Cimini V; Zullo F
Fertil Steril; 2005 Jul; 84(1):154-61. PubMed ID: 16009171
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
[TBL] [Abstract][Full Text] [Related]
16. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.
Palomba S; Affinito P; Tommaselli GA; Nappi C
Fertil Steril; 1998 Jul; 70(1):111-8. PubMed ID: 9660431
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis.
Takeuchi H; Kobori H; Kikuchi I; Sato Y; Mitsuhashi N
J Obstet Gynaecol Res; 2000 Oct; 26(5):325-31. PubMed ID: 11147718
[TBL] [Abstract][Full Text] [Related]
18. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography.
Aleem FA; Predanic M
Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
20. The combined effect of a GnRH analog in premenopause plus postmenopausal estrogen deficiency for the treatment of uterine leiomyomas in perimenopausal women.
de Aloysio D; Altieri P; Pretolani G; Romeo A; Paltrinieri F
Gynecol Obstet Invest; 1995; 39(2):115-9. PubMed ID: 7737580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]